Clinical Research Directory
Browse clinical research sites, groups, and studies.
Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
Sponsor: Alexion Pharmaceuticals, Inc.
Summary
The primary objective of this study is to evaluate the safety and tolerability of tarperprumig in participants with newly diagnosed or relapsing anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis.
Official title: Phase 2, Randomized, Double-Blind, Placebo-controlled, Parallel-Group, Multicenter Study to Evaluate the Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (I TRANSCEND)
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
75
Start Date
2025-11-26
Completion Date
2028-02-14
Last Updated
2026-04-07
Healthy Volunteers
No
Interventions
Placebo
Participants will receive placebo.
Tarperprumig
Participants will receive tarperprumig.
Locations (78)
Research Site
Ciudad de Buenos Aires, Argentina
Research Site
Ciudad de Buenos Aires, Argentina
Research Site
La Plata, Argentina
Research Site
Rosario, Argentina
Research Site
San Juan Bautista, Argentina
Research Site
Santa Fe, Argentina
Research Site
Clayton, Australia
Research Site
Heidelberg, Australia
Research Site
Nedlands, Australia
Research Site
Wollongong, Australia
Research Site
Barretos, Brazil
Research Site
Belo Horizonte, Brazil
Research Site
Porto Alegre, Brazil
Research Site
Recife, Brazil
Research Site
São Paulo, Brazil
Research Site
São Paulo, Brazil
Research Site
São Paulo, Brazil
Research Site
Calgary, Alberta, Canada
Research Site
Edmonton, Alberta, Canada
Research Site
Etobicoke, Ontario, Canada
Research Site
Hamilton, Ontario, Canada
Research Site
Toronto, Ontario, Canada
Research Site
Montreal, Quebec, Canada
Research Site
Baotou, China
Research Site
Beijing, China
Research Site
Beijing, China
Research Site
Guangzhou, China
Research Site
Hangzhou, China
Research Site
Nanchang, China
Research Site
Shenzhen, China
Research Site
Marseille, France
Research Site
Paris, France
Research Site
Paris, France
Research Site
Strasbourg, France
Research Site
Toulouse, France
Research Site
Berlin, Germany
Research Site
Essen, Germany
Research Site
Göttingen, Germany
Research Site
Ludwigshafen, Germany
Research Site
München, Germany
Research Site
Brescia, Italy
Research Site
Padova, Italy
Research Site
Pavia, Italy
Research Site
Pisa, Italy
Research Site
Gdansk, Poland
Research Site
Krakow, Poland
Research Site
Poznan, Poland
Research Site
Warsaw, Poland
Research Site
Daegu, South Korea
Research Site
Daegu, South Korea
Research Site
Daejeon, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Wŏnju, South Korea
Research Site
Barcelona, Spain
Research Site
Pamplona, Spain
Research Site
San Sebastián de los Reyes, Spain
Research Site
Santander, Spain
Research Site
Seville, Spain
Research Site
Kaohsiung City, Taiwan
Research Site
Taichung, Taiwan
Research Site
Taipei, Taiwan
Research Site
Taoyuan District, Taiwan
Research Site
Altındağ, Turkey (Türkiye)
Research Site
Ankara, Turkey (Türkiye)
Research Site
Center, Turkey (Türkiye)
Research Site
Istanbul, Turkey (Türkiye)
Research Site
Istanbul, Turkey (Türkiye)
Research Site
Kocaeli, Turkey (Türkiye)
Research Site
Birmingham, United Kingdom
Research Site
Cambridge, United Kingdom
Research Site
Leicester, United Kingdom
Research Site
London, United Kingdom
Research Site
London, United Kingdom
Research Site
Manchester, United Kingdom